Annals of surgical oncology

publication venue for

Correction: Evaluating the Effect of MarginProbe^® Use on Re-excisions After Partial Mastectomy: A Single-Institution Analysis. 2025
Correction to: The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma. 2021
Correction to: Two-Stage Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss. 2021
Correction to: Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer. 2020
Erratum to: Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review. 2015
Minimally invasive radio-guided surgery for primary hyperparathyroidism. 2007
Preoperative Biliary Drainage with Metal Stent Versus Early Surgery in Patients with Pancreatic Cancer: A Randomized Clinical Trial. 2026
ASO Visual Abstract: The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility Criteria.. 33. 2026
ASO Visual Abstract: Alcohol Use Disorder Versus Adverse In-hospital Outcomes After Radical Cystectomy and Ileal Conduit Urinary Diversion. 2026
Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder Cancer. 2026
Surgical Oncology Heroes and Legends: Dr. Harold Freeman as Interviewed by Dr. Lisa Newman. 2026
ASO Visual Abstract: Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy. 2026
ASO Author Reflections: Eliminating Surgical Oncology Health Disparities Through Actionable Change. 2026
ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy. 2026
ASO Visual Abstract: Rurality and Income on Breast Cancer Outcomes: An Analysis of the SEER Database. 2026
Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy. 2026
ASO Education and Training: Taking the Next Step in Surgical Oncology Health Disparities Research: Identifying Root Causes and Targets for Actionable Change. 2026
Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients with Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial. 2026
ASO Visual Abstract: Practice Patterns of Graduates from a Surgical Oncology Fellowship Program. 2026
Rurality and Income on Breast Cancer Outcomes: An Analysis of the SEER Database. 2026
Practice Patterns of Graduates from a Surgical Oncology Fellowship Program. 2026
ASO Visual Abstract: Short- and Long-term Patient Outcomes in Hospitals Primarily Serving Colorectal Cancer Patients from High-Poverty Areas-An Observational Cohort Study. 2026
ASO Visual Abstract: Long-Term Oncologic Outcomes Following Pathologic Complete Response for Esophageal Cancer. 2025
Short-and Long-term Patient Outcomes in Hospitals Primarily Serving Patients with Colorectal Cancer from High-Poverty Areas-An Observational Cohort Study. 2025
ASO Visual Abstract: Surgical Oncologists for Sustainability-A Statement from the SSO Surgical Oncologists for Sustainability Committee. 2025
The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility Criteria.. 33. 2025
ASO Author Reflections:Bringing Sustainability to the Forefront of Surgical Oncology. 2025
Long-term Oncologic Outcomes Following Pathologic Complete Response for Esophageal Cancer. 2025
In-Person and Virtual Interviews for Complex General Surgical Oncology Fellowship: An Applicant's Perspective. 2025
The Impact of Adjuvant Radiotherapy Administration on Disease-Specific Survival in Patients with Parathyroid Carcinoma.. 33. 2025
ASO Author Reflections: Reconstructing Equity: Policy's Role in Post-Mastectomy Breast Cancer Care.. 32. 2025
Closing the Gap: Disparities in Breast Reconstruction After Mastectomy.. 32. 2025
Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study. 2025
Reduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases. 2025
ASO Visual Abstract: Combined Portal and Hepatic Vein Embolization Produces Greater Hypertrophy than Portal Vein Embolization Alone with Similar Post-Hepatectomy Outcomes and is Not Impacted by Hepatic Artery Infusion Chemotherapy. 2025
ASO Visual Abstract: Outcomes in Locally Advanced Pancreatic Cancer After Induction Ablative Radiation Therapy and Resection. 2025
Precision in Liver Surgery: A Comparative Analysis of Volumetry Techniques. 2025
ASO Visual Abstract: Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas.. 32. 2025
Combined Portal and Hepatic Vein Embolization Produces Greater Hypertrophy than Portal Vein Embolization Alone with Similar Post-Hepatectomy Outcomes and is not Impacted by Hepatic Artery Infusion Chemotherapy. 2025
Differential Effects of Endocrine Therapy Type on Quality of Life in Older (≥70 Years) Women with Early-Stage Breast Cancer.. 32. 2025
Outcomes in Locally Advanced Pancreatic Cancer After Induction Ablative Radiation Therapy and Resection.. 32. 2025
ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.. 32. 2025
ASO Visual Abstract: Surgical Site Infections in Simultaneous Colorectal and Liver Resections for Metastatic Colorectal Adenocarcinoma.. 32. 2025
Rare but Complex: Outcomes and Challenges in Managing Composite Follicular-Anaplastic Thyroid Cancer.. 32. 2025
ASO Author Reflections: Risk Stratification Using Genomic Data for Early-Stage Colon Cancer.. 32. 2025
ASO Author Reflections: Active Surveillance for Local Colorectal Neuroendocrine Tumors-Patient Selection is Paramount.. 32. 2025
Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer.. 32. 2025
Impact of Delayed Surgery on Local Colorectal Neuroendocrine Tumors: Is Surveillance a Feasible Option?. 32. 2025
Robotic Versus Open Placement of Hepatic Artery Infusion Pumps.. 32. 2025
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.. 32. 2025
Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas.. 32. 2024
ASO Author Reflections: Targeted Treatment for a Rare Subset of Pancreatic Cancer? 2024
Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional Cohort.. 32. 2024
Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma.. 32. 2024
Surgical Site Infections in Simultaneous Colorectal and Liver Resections for Metastatic Colorectal Adenocarcinoma.. 32. 2024
ASO Author Reflections: Addressing Radioactive Iodine Recommendations in Low-to-Intermediate Risk Papillary Thyroid Cancer.. 32. 2024
The Impact of Radioactive Iodine on Disease-Specific Survival in Low-to-Intermediate Risk N1b Papillary Thyroid Carcinoma.. 32. 2024
Computed Tomography-Based Radiomics with Machine Learning Outperforms Radiologist Assessment in Estimating Colorectal Liver Metastases Pathologic Response After Chemotherapy.. 31. 2024
Disappearing Signet Ring Cell Adenocarcinoma in Gastric Cancer Patients. 2024
Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.. 31. 2024
Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial.. 31. 2024
Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers. 2024
Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap. 2024
Feasibility and Efficacy of Sentinel Lymph Node Mapping in Gastric Cancer. 2024
Evaluating the Effect of MarginProbe^® Use on Re-excisions After Partial Mastectomy: A Single-Institution Analysis.. 31. 2024
ASO Author Reflections: Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap. 2024
Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer Database.. 31. 2024
Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients.. 31. 2024
Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database.. 31. 2024
Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes.. 31. 2024
Breast Cancer Incidence Among Asian American Women in New York City: Disparities in Screening and Presentation.. 31. 2023
Timing to Surgery and Lymph Node Upstaging in Gastric Cancer: An NCDB Analysis.. 31. 2023
Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies.. 31. 2023
Perceptions of Readiness for Practice After Complex General Surgical Oncology Fellowship: A Survey Study.. 31. 2023
Robot-Assisted Surgery and Racial and Ethnic Disparities in Post-Prostatectomy Outcomes Among Prostate Cancer Patients.. 31. 2023
Addressing Data Aggregation and Data Inequity in Race and Ethnicity Reporting and the Impact on Breast Cancer Disparities.. 31. 2023
Treatment Patterns and Outcomes in Pancreatic Cancer: A Comparative Analysis of Ontario and the USA.. 31. 2023
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.. 31. 2023
The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy.. 30. 2023
Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical Trial.. 30. 2023
Lymph Node Metastases and Associated Recurrence-Free Survival in Microsatellite Stable and Unstable Colon Cancer.. 30. 2023
Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases.. 30. 2023
Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter Study.. 30. 2023
Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.. 30. 2023
Younger Patients with Colon Cancer are More Likely to Experience Financial Toxicity Than Older Patients.. 30. 2023
Different Methods of Minimally Invasive Esophagojejunostomy After Total Gastrectomy for Gastric Cancer: Outcomes from Two Experienced Centers.. 30. 2023
Rates and Patterns of Recurrence After Microwave Ablation of Colorectal Liver Metastases: A Per Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.. 30. 2023
Risk Factors and Outcomes of Open Conversion During Minimally Invasive Major Hepatectomies: An International Multicenter Study on 3880 Procedures Comparing the Laparoscopic and Robotic Approaches.. 30. 2023
Assessing the Complex General Surgical Oncology Pipeline: Trends in Race and Ethnicity Among US Medical Students, General Surgery Residents, and Complex General Surgical Oncology Trainees.. 30. 2023
MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival.. 30. 2023
Perineural Invasion in Papillary Thyroid Cancer: A Rare Indicator of Aggressive Disease.. 30. 2023
Tumor Regression Grade and Overall Survival following Gastrectomy with Preoperative Therapy for Gastric Cancer.. 30. 2023
A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.. 30. 2023
Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy.. 30. 2023
Coexisting Papillary and Anaplastic Thyroid Cancer: Elucidating the Spectrum of Aggressive Behavior.. 30. 2022
Regional Patterns of Hospital-Level Guideline Adherence in Gastric Cancer: An Analysis of the National Cancer Database.. 30. 2022
Robotic Versus Laparoscopic Left and Extended Left Hepatectomy: An International Multicenter Study Propensity Score-Matched Analysis.. 29. 2022
Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.. 29. 2022
Breast-Specific Sensuality in Breast Cancer Survivors: Sexually Active or Not.. 29. 2022
ASO Author Reflections: Breast-Specific Sensuality in the Sexually Inactive Breast Cancer Survivor.. 29. 2022
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.. 29. 2022
Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and Prognoses.. 29. 2022
Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.. 29. 2022
Postmastectomy Breast Reconstruction Patterns at an Urban Academic Hospital and the Impact of Surgeon Gender.. 29. 2022
Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis?. 29. 2022
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.. 29. 2022
Surgical Treatment of Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: An NCDB Analysis.. 29. 2022
RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype. 2022
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: PRODIGE 23 Trial. 2021
ASO Author Reflections: Hepatic Arterial Infusion Pump Can Be Placed Simultaneously with Primary Tumor Resection in Colon Cancer Patients with Synchronous Metastases.. 29. 2021
Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement.. 29. 2021
Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC).. 29. 2021
Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival.. 29. 2021
Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.. 28. 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.. 29. 2021
ASO Author Reflections: Preventing Nipple Loss by Surgical Delay in Nipple-Sparing Mastectomy.. 29. 2021
The Impact of Radiotherapy Delay in Breast Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures.. 29. 2021
Two-Stage Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss.. 28. 2021
Percutaneous Cryoablation Provides Disease Control for Extra-Abdominal Desmoid-Type Fibromatosis Comparable with Surgical Resection.. 29. 2021
ASO Author Reflections: Colorectal Cancer, Bias, and the Surgeon: What is Next?. 29. 2021
ASO Author Reflections: Reexamining Disparities in Surgical Oncology: Lets Expand Our Views.. 28. 2021
Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.. 28. 2021
Assessment of Frailty Can Guide Decision Making for Utilization of Sentinel Lymph Node Biopsy in Patients with Thick Melanoma.. 28. 2021
ASO Author Reflections: Hilar Cholangiocarcinoma.. 28. 2021
Arm Morbidity After Local Therapy for Young Breast Cancer Patients.. 28. 2021
Intraductal Papilloma of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance. 2021
Tumor-Nipple Distance of ≥ 1 cm Predicts Negative Nipple Pathology After Neoadjuvant Chemotherapy.. 28. 2021
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer Resection.. 28. 2021
Will It Play in Peoria? A Pilot Study of a Robotic Skills Curriculum for Surgical Oncology Fellows.. 28. 2021
Radial Scars and Complex Sclerosing Lesions of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance.. 28. 2021
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence.. 28. 2021
A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma. 2021
Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer.. 28. 2020
ASO Author Reflections: Access to Healthcare Does Not Mean Access to Health: Food Deserts in the Land of Plenty.. 28. 2020
Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched Study.. 28. 2020
Association of Living in Urban Food Deserts with Mortality from Breast and Colorectal Cancer.. 28. 2020
Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?. 27. 2020
Disparate and Alarming Impact of Gastrointestinal Cancers in Young Adult Patients.. 28. 2020
Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study.. 27. 2020
Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.. 28. 2020
Is a Prophylactic Central Compartment Neck Dissection Required in Papillary Thyroid Carcinoma Patients with Clinically Involved Lateral Compartment Lymph Nodes?. 28. 2020
The Use and Benefit of Adjuvant Radiotherapy in Parathyroid Carcinoma: A National Cancer Database Analysis.. 28. 2020
Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.. 28. 2020
The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.. 27. 2020
Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy.. 28. 2020
ASO Author Reflections: Improved Survival for Stage IV Breast Cancer: Considerations for Surgery in the Era of HER2-Targeted Therapy.. 27. 2020
The Impact of Primary Tumor Surgery on Survival in HER2 Positive Stage IV Breast Cancer Patients in the Current Era of Targeted Therapy.. 27. 2020
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.. 27. 2019
Characterization of Recurrences Following Second Breast-Conserving Surgery with Intraoperative Radiotherapy.. 27. 2019
Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.. 26. 2019
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.. 27. 2019
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance).. 26. 2019
Long-Term Oncologic Outcomes After Curative Resection of Familial Medullary Thyroid Carcinoma.. 26. 2019
Maintenance of Certification and Continuing Medical Education: Are They Still Required?. 26. 2019
Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors.. 26. 2019
Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.. 26. 2019
Assessment of the Value of Comorbidity Indices for Risk Adjustment in Colorectal Surgery Patients.. 26. 2019
Role of the Interval from Completion of Neoadjuvant Therapy to Surgery in Postoperative Morbidity in Patients with Locally Advanced Rectal Cancer.. 26. 2019
Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor.. 26. 2019
Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.. 26. 2019
ASO Author Reflections: Informing Patients About New Genetic Testing.. 26. 2019
Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN).. 25. 2019
ASO Author Reflections: The Role of Robotic Surgery in Liver Resection.. 26. 2018
ASO Author Reflections: PTTG1 Protein Expression in Adrenocortical Carcinoma.. 26. 2018
Is Robotic-Assisted Surgery Safe in the Elderly Population? An Analysis of Gynecologic Procedures in Patients ≥ 65 Years Old.. 26. 2018
Robotic Versus Open Minor Liver Resections of the Posterosuperior Segments: A Multinational, Propensity Score-Matched Study.. 26. 2018
Multifocal/Multicentric Ipsilateral Invasive Breast Carcinomas with Similar Histology: Is Multigene Testing of All Individual Foci Necessary?. 26. 2018
Implications of Internal Mammary Lymph Node Sampling During Microsurgical Breast Reconstruction.. 25. 2018
Long-Term Oncologic Outcomes Following Robotic Liver Resections for Primary Hepatobiliary Malignancies: A Multicenter Study.. 25. 2018
Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.. 25. 2018
Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant Chemotherapy.. 25. 2018
The 21-Gene Recurrence Score in Male Breast Cancer.. 25. 2018
Predicting Survival and Response to Treatment in Gastroesophageal Neuroendocrine Tumors: An Analysis of the National Cancer Database.. 25. 2018
Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma.. 25. 2018
Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis.. 25. 2018
Global Curriculum in Research Literacy for the Surgical Oncologist.. 25. 2017
Global Variations in the Level of Cancer-Related Research Activity and Correlation to Cancer-Specific Mortality: Proposal for a Global Curriculum.. 25. 2017
Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.. 25. 2017
STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.. 25. 2017
The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.. 25. 2017
Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.. 24. 2017
Comparison of Young Patients with Gastric Cancer in the United States and China.. 24. 2017
Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors.. 24. 2017
The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma.. 24. 2017
Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.. 24. 2017
Endoscopic Ultrasound as a Pretreatment Clinical Staging Tool for Gastric Cancer: Association with Pathology and Outcome.. 24. 2017
2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy.. 24. 2017
Association Between Recurrence and Re-Excision for Close and Positive Margins Versus Observation in Patients with Benign Phyllodes Tumors.. 24. 2017
Breast Cancer Disparities: Socioeconomic Factors versus Biology.. 24. 2017
Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?. 24. 2017
Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.. 24. 2017
Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.. 24. 2017
Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.. 24. 2017
Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer.. 24. 2017
Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.. 24. 2017
Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.. 24. 2017
Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.. 24. 2017
Is Routine Axillary Imaging Necessary in Clinically Node-Negative Patients Undergoing Neoadjuvant Chemotherapy?. 24. 2017
Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?. 24. 2017
Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.. 24. 2017
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.. 24. 2016
Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy.. 24. 2016
Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.. 24. 2016
Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age.. 24. 2016
Establishing a Cancer Research Consortium in Low- and Middle-Income Countries: Challenges Faced and Lessons Learned.. 24. 2016
Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes.. 24. 2016
Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study.. 23. 2016
Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study.. 24. 2016
Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor.. 24. 2016
Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer.. 23. 2016
Minimally Invasive Gastric Surgery.. 23. 2016
Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.. 23. 2016
How Often Is Treatment Effect Identified in Axillary Nodes with a Pathologic Complete Response After Neoadjuvant Chemotherapy?. 23. 2016
Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery.. 23. 2016
Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.. 23. 2016
Oncologic Outcomes After Nipple-Sparing Mastectomy.. 23. 2016
Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer Patients.. 23. 2016
How Beneficial is Follow-Up Mammography in Elderly Breast Cancer Survivors?. 23. 2016
A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072.. 23. 2016
Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group.. 23. 2016
Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.. 23. 2016
Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?. 23. 2016
Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.. 23. 2016
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.. 23. 2016
Global Curriculum in Surgical Oncology.. 23. 2016
Variations in Training of Surgical Oncologists: Proposal for a Global Curriculum.. 23. 2016
Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.. 23. 2016
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.. 23. 2016
Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon.. 23. 2016
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery.. 23. 2016
Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant.. 23. 2016
Fertility Preservation for the Young Breast Cancer Patient.. 23. 2016
Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial.. 23. 2016
Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.. 23. 2016
Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer.. 23. 2016
Patterns and Predictors of Weight Loss After Gastrectomy for Cancer.. 23. 2016
Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.. 23. 2015
Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.. 23. 2015
Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile?. 23. 2015
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.. 23. 2015
Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.. 23. 2015
Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?. 23. 2015
Which Surgical Attitude to Choose in the Context of Non-Resectability of Ovarian Carcinomatosis: Beyond Gross Residual Disease Considerations.. 23. 2015
Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging.. 22 Suppl 3. 2015
Prognostic Performance of Current Stage III Oral Cancer Patients After Curative Intent Resection: Evidence to Support a Revision of the American Joint Committee on Cancer Staging System.. 22 Suppl 3. 2015
Breast-Conserving Surgery in Bilateral Breast Cancer.. 22. 2015
Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma.. 22 Suppl 3. 2015
Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.. 22. 2015
Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.. 23. 2015
Rethinking the Local Therapy of Breast Cancer: Integration of Biology and Anatomy.. 22. 2015
Skin Flap Necrosis After Mastectomy With Reconstruction: A Prospective Study.. 23. 2015
Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed?. 22 Suppl 3. 2015
The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.. 22 Suppl 3. 2015
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases.. 22 Suppl 3. 2015
Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival.. 22 Suppl 3. 2015
A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema.. 22 Suppl 3. 2015
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma.. 22. 2015
Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.. 22 Suppl 3. 2015
Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping.. 23. 2015
Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.. 22. 2015
Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?. 22. 2015
Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules.. 22. 2015
Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.. 22. 2015
Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized Cases.. 22. 2015
Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?. 22. 2015
Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women.. 22. 2015
Distant Metastases in Patients with Carcinoma of the Major Salivary Glands.. 22. 2015
Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus.. 23. 2015
Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.. 22. 2015
Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review.. 22. 2015
Laparoscopic Versus Open Gastrectomy for Gastric Adenocarcinoma in the West: A Case-Control Study.. 22. 2015
Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.. 22. 2015
Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.. 22. 2015
Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.. 22. 2015
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection.. 22. 2015
The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy.. 22. 2015
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.. 22. 2014
Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.. 22. 2014
Clinical features and outcome of primary pancreatic lymphoma.. 22. 2014
A comparison of complication rates in early-stage breast cancer patients treated with brachytherapy versus whole-breast irradiation.. 22. 2014
Development and assessment of Memorial Sloan Kettering Cancer Center's Surgical Secondary Events grading system.. 22. 2014
Esophageal reinforcement with an extracellular scaffold during total gastrectomy for gastric cancer.. 22. 2014
Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison.. 22. 2014
Elective neck dissection in patients with head and neck adenoid cystic carcinoma: an international collaborative study.. 22. 2014
Level 7 disease does not confer worse outcome than level 6 disease in differentiated thyroid cancer.. 22. 2014
Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases.. 21. 2014
Initial experience with genomic profiling of heavily pretreated breast cancers.. 21. 2014
Readmission after pancreatic resection: causes and causality pattern.. 21. 2014
International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.. 21. 2014
Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement.. 21. 2014
A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer.. 21. 2014
A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases.. 21. 2014
Commentary on the Canadian National Breast Screening study.. 21. 2014
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors.. 21 Suppl 4. 2014
Observation after a positive sentinel lymph node biopsy in patients with melanoma.. 21. 2014
Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study.. 21. 2014
The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer.. 21. 2014
The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma.. 21. 2014
A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum.. 21. 2014
Implant breast reconstruction and radiation: a multicenter analysis of long-term health-related quality of life and satisfaction.. 21. 2014
Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study.. 21. 2014
Treatment of the neck in carcinoma of the parotid gland.. 21. 2014
Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.. 21. 2014
Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancer.. 21. 2014
Neoadjuvant radiation therapy prior to total mesorectal excision for rectal cancer is not associated with postoperative complications using current techniques.. 21. 2014
Is gastric cancer different in Korea and the United States? Impact of tumor location on prognosis.. 21. 2014
A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.. 21. 2014
Basal subtype, as approximated by triple-negative phenotype, is associated with locoregional recurrence in a case-control study of women with 0-3 positive lymph nodes after mastectomy.. 21. 2014
Anaplastic thyroid carcinoma: a 25-year single-institution experience.. 21. 2014
Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes.. 21. 2014
Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma.. 21. 2014
Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.. 21. 2014
Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.. 21. 2013
Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma.. 21. 2013
Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy.. 21. 2013
Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.. 21. 2013
Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.. 21. 2013
Chest and upper body morbidity following immediate postmastectomy breast reconstruction.. 21. 2013
Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.. 21. 2013
Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands.. 21. 2013
Postoperative pain medication requirements in patients undergoing computer-assisted (“Robotic”) and standard laparoscopic procedures for newly diagnosed endometrial cancer.. 20. 2013
The role of thyroidectomy in metastatic disease to the thyroid gland.. 21. 2013
Impact of margin assessment method on positive margin rate and total volume excised.. 21. 2013
Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.. 20. 2013
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy.. 21. 2013
Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.. 20. 2013
The value of 6-month interval imaging after benign radiologic-pathologic concordant minimally invasive breast biopsy.. 20. 2013
Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm.. 20. 2013
Radioactive seed localization compared to wire localization in breast-conserving surgery: initial 6-month experience.. 20. 2013
Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.. 20. 2013
Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation.. 20 Suppl 3. 2013
Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.. 20. 2013
Prognosis of acral melanoma: a series of 281 patients.. 20. 2013
Does bethesda category predict aggressive features in malignant thyroid nodules?. 20. 2013
Clinical nodal stage is a significant predictor of outcome in patients with oral cavity squamous cell carcinoma and pathologically negative neck metastases: results of the international consortium for outcome research.. 20. 2013
Toward better soft tissue sarcoma staging: building on american joint committee on cancer staging systems versions 6 and 7.. 20. 2013
Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.. 20. 2013
Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?. 20. 2013
Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases.. 20. 2013
Esophagojejunal reconstruction after total gastrectomy for gastric cancer using a transorally inserted anvil delivery system.. 20. 2013
Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC<7 cm.. 20. 2013
Association of positive transection margins with gastric cancer survival and local recurrence.. 20. 2013
Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma.. 20. 2013
Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion.. 20. 2013
Cause-specific mortality in patients with mucoepidermoid carcinoma of the major salivary glands.. 20. 2013
Anastomotic leak following low anterior resection in stage IV rectal cancer is associated with poor survival.. 20. 2013
Predictors of survival and recurrence in primary leiomyosarcoma.. 20. 2013
Locoregional lymphadenectomy in the surgical management of anorectal melanoma.. 20. 2013
Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: a contemporary analysis.. 20. 2012
Lumpectomy closure technique does not affect dosimetry in patients undergoing external-beam-based accelerated partial breast irradiation.. 20. 2012
Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression.. 20. 2012
A phase II, randomized, controlled trial of acupuncture for reduction of Postcolectomy Ileus.. 20. 2012
Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer.. 20. 2012
Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation.. 20. 2012
Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.. 20. 2012
Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor.. 20. 2012
Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.. 20. 2012
Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer.. 20. 2012
Illness-related distress in women with clinically localized cutaneous melanoma.. 20. 2012
Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.. 20. 2012
Should breast density influence patient selection for breast-conserving surgery?. 20. 2012
Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.. 20. 2012
Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence.. 20. 2012
Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.. 20. 2012
Tumor proximity to the recurrent laryngeal nerve in patients with primary hyperparathyroidism undergoing parathyroidectomy.. 19. 2012
Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.. 19. 2012
The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma.. 19. 2012
Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies.. 19. 2012
Synchronous resection of primary and liver metastases for neuroendocrine tumors.. 19. 2012
Evaluation of lymphadenectomy in patients receiving neoadjuvant radiotherapy for rectal adenocarcinoma.. 19. 2012
Society of Surgical Oncology Heritage Award: honoring William C. Wood, MD.. 19. 2012
FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.. 19. 2012
The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy.. 19. 2012
Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.. 19. 2012
Resection of adrenocortical carcinoma liver metastasis: is it justified?. 19. 2012
A probabilistic analysis of completely excised high-grade soft tissue sarcomas of the extremity: an application of a Bayesian belief network.. 19. 2012
Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.. 19. 2012
Bioluminescence imaging serves as a dynamic marker for guiding and assessing thermal treatment of cancer in a preclinical model.. 19. 2012
Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.. 19. 2012
Tobacco use is associated with increased recurrence and death from gastric cancer.. 19. 2012
A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.. 19 Suppl 3. 2012
Training a new generation of breast surgeons: are we succeeding?. 19. 2012
Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease.. 19. 2011
Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib.. 19. 2011
Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma.. 19. 2011
Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors.. 19. 2011
Is there a low-grade precursor pathway in breast cancer?. 19. 2011
Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.. 19. 2011
Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.. 19. 2011
Patterns of recurrence after ablation of colorectal cancer liver metastases.. 19. 2011
Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience.. 18. 2011
A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology.. 19. 2011
Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades.. 19. 2011
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.. 19. 2011
MRI versus breast-specific gamma imaging (BSGI) in newly diagnosed ductal cell carcinoma-in-situ: a prospective head-to-head trial.. 19. 2011
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection.. 19. 2011
Is port site resection necessary in the surgical management of gallbladder cancer?. 19. 2011
Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group.. 18. 2011
Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.. 18. 2011
CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.. 19 Suppl 3. 2011
Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.. 18. 2011
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.. 18. 2011
Predictors of survival in mucosal melanoma of the head and neck.. 18. 2011
Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema.. 18. 2011
Predictive value of cytologic atypia in indeterminate thyroid fine-needle aspirate biopsies.. 18. 2011
Cancer surgeons' distress and well-being, I: the tension between a culture of productivity and the need for self-care.. 18. 2011
Cancer surgeons' distress and well-being, II: modifiable factors and the potential for organizational interventions.. 18. 2011
Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.. 18. 2011
Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison.. 18. 2011
Receipt of delayed breast reconstruction after mastectomy: do women revisit the decision?. 18. 2011
Impact of a temporary stoma on the quality of life of rectal cancer patients undergoing treatment.. 18. 2010
Implementation of a percutaneous core needle biopsy training program: results from the University of Michigan-Komfo Anokye Teaching Hospital breast cancer research partnership.. 18. 2010
Treatment and outcome of patients with gastric remnant cancer after resection for peptic ulcer disease.. 18. 2010
Surgical management of metastases to the thyroid gland.. 18. 2010
Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases.. 18. 2010
Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma.. 18. 2010
Electronic synoptic operative reporting for thyroid surgery using an electronic data management system: potential for prospective multicenter data collection.. 18. 2010
Thyroid isthmusectomy for well-differentiated thyroid cancer.. 18. 2010
Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia.. 18. 2010
Controversies in breast surgery.. 17 Suppl 3. 2010
Nipple-areolar complex-sparing mastectomy: feasibility, patient selection, and technique.. 17 Suppl 3. 2010
Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy.. 18. 2010
Cumulative imaging radiation exposure following breast-conservation therapy.. 18. 2010
Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.. 18. 2010
Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay.. 17. 2010
Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients.. 17. 2010
Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema.. 17. 2010
Tissue expander breast reconstruction is not associated with an increased risk of lymphedema.. 17. 2010
Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction.. 17. 2010
Is there a role for MRI in the preoperative assessment of patients with DCIS?. 17. 2010
Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality.. 17. 2010
Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.. 17. 2010
Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy.. 17. 2010
Multicentric study on robotic tumor-specific mesorectal excision for the treatment of rectal cancer.. 17. 2010
Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.. 17. 2009
Primary malignant giant-cell tumor of bone has high survival rate.. 17. 2009
Defining surgical indications for type I gastric carcinoid tumor.. 16. 2009
KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer.. 17. 2009
Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.. 16. 2009
KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases.. 17. 2009
Presenting features of breast cancer differ by molecular subtype.. 16. 2009
Micromedullary thyroid cancer: how micro is truly micro?. 16. 2009
T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.. 16. 2009
Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.. 16. 2009
Valgus ankle deformity after vascularized fibular reconstruction for oncologic disease.. 16. 2009
Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes.. 16. 2009
Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study.. 16. 2009
Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging.. 16. 2009
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.. 16. 2009
Partial upper sternotomy for anterosuperior mediastinal surgery: an institutional experience.. 16. 2009
The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.. 16. 2009
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy.. 16. 2009
Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention.. 16. 2008
Analysis of the extent of resection for adenocarcinoma of the gallbladder.. 16. 2008
Breast cancer risk factors in younger and older women.. 16. 2008
Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma.. 16. 2008
Preoperative needle biopsy as a potential quality measure in breast cancer surgery.. 16. 2008
The penetratin sequence in the anticancer PNC-28 peptide causes tumor cell necrosis rather than apoptosis of human pancreatic cancer cells.. 15. 2008
Why do patients with low-grade soft tissue sarcoma die?. 15. 2008
Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence.. 15. 2008
Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma.. 15. 2008
The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.. 15. 2008
Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma.. 15. 2008
Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy.. 15. 2008
A single-institution validation of the AJCC staging system for stage IV melanoma.. 15. 2008
The functional impact on voice of sternothyroid muscle division during thyroidectomy.. 15. 2008
Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells.. 15. 2008
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.. 15. 2008
Predictors of re-excision among women undergoing breast-conserving surgery for cancer.. 15. 2008
Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases.. 15. 2008
The influence of age on the breast surgery decision-making process.. 15. 2007
Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.. 15. 2007
Sentinel lymph node evaluation does not improve staging accuracy in colon cancer.. 15. 2007
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?. 14. 2007
Desmoid tumors (fibromatoses) of the breast: a 25-year experience.. 15. 2007
Partial penectomy for patients with squamous cell carcinoma of the penis: the Memorial Sloan-Kettering experience.. 14. 2007
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation.. 15. 2007
Sentinel node positivity rates with and without frozen section for breast cancer.. 15. 2007
Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology.. 14. 2007
Conflicts in decision-making for breast cancer surgery.. 14. 2007
Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.. 14. 2007
Stage-IV melanoma and pulmonary metastases: factors predictive of survival.. 14. 2007
Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma.. 14. 2007
Laparoscopic adrenalectomy for isolated adrenal metastasis.. 14. 2007
The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery.. 14. 2007
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.. 14. 2007
Young age influences treatment but not outcome of colon cancer.. 14. 2007
Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast.. 14. 2007
Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.. 14. 2007
Comparing surgical outcomes in obese women undergoing laparotomy, laparoscopy, or laparotomy with panniculectomy for the staging of uterine malignancy.. 14. 2007
Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.. 14. 2007
Use of an artificial lymphatic system during carboplatin infusion to improve canine osteosarcoma blood flow and clinical response.. 14. 2007
Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy.. 14. 2007
Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer.. 14. 2007
The role of sentinel lymph node biopsy in Paget's disease of the breast.. 14. 2007
The pedicled latissimus dorsi flap for shoulder reconstruction after sarcoma resection.. 14. 2007
Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessment.. 14. 2007
Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent.. 14. 2007
Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument?. 14. 2007
Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread.. 14. 2007
Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.. 14. 2006
Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients.. 13. 2006
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.. 14. 2006
Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment.. 14. 2006
Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.. 14. 2006
Outcome of metastatic GIST in the era before tyrosine kinase inhibitors.. 14. 2006
Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma.. 14. 2006
FDG-PET detected thyroid incidentalomas: need for further investigation?. 14. 2006
Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.. 13. 2006
A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography.. 13. 2006
Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland.. 23. 2006
18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma.. 13. 2006
Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients.. 13. 2006
Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.. 13. 2006
Results of sentinel lymph node biopsy in patients with thin melanoma.. 13. 2006
Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.. 13. 2006
Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.. 13. 2006
Effectiveness of palliative procedures for intra-abdominal sarcomas.. 12. 2005
Herpes simplex virus amplicon delivery of a hypoxia-inducible soluble vascular endothelial growth factor receptor (sFlk-1) inhibits angiogenesis and tumor growth in pancreatic adenocarcinoma.. 12. 2005
Limitations of ampullectomy in the treatment of nonfamilial ampullary neoplasms.. 12. 2005
Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.. 12. 2005
Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?. 12. 2005
Ductal lavage findings in women with mammographic microcalcifications undergoing biopsy.. 12. 2005
A tat fusion protein-based tumor vaccine for breast cancer.. 12. 2005
The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection.. 12. 2005
Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma.. 12. 2005
Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.. 12. 2005
Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas.. 12. 2005
The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients.. 12. 2005
Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study.. 12. 2005
A predictive model for the development of hormone-responsive breast cancer.. 12. 2005
Ankle instability after vascularized fibular harvest for tumor reconstruction.. 12. 2004
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.. 11. 2004
Factors associated with residual breast cancer after re-excision for close or positive margins.. 11. 2004
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy.. 11. 2004
A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy.. 11. 2004
Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.. 11. 2004
Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer.. 11. 2004
Head and neck soft tissue sarcomas: a multivariate analysis of outcomes.. 11. 2004
A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer.. 11. 2004
Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial.. 11. 2004
Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A.. 11. 2004
Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma.. 11. 2004
Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer.. 11. 2004
Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer.. 11. 2004
Operative surgical education: results of a society of surgical oncology fellowship survey and proposal for an operative database.. 11. 2004
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?. 11. 2004
Survival and recurrence after breast cancer in BRCA1/2 mutation carriers.. 11. 2004
Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations.. 11. 2004
Breast cancer in patients with residual invasive carcinoma is more accurately staged with additive tumor size assessment.. 11. 2004
Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.. 11. 2004
Primary vaginal melanoma: a critical analysis of therapy.. 11. 2004
Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary malignancies.. 10. 2003
Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma.. 10. 2003
Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome.. 10. 2003
Prospective identification of risk factors for wound infection after lower extremity oncologic surgery.. 10. 2003
Adult spermatic cord sarcomas: management and results.. 10. 2003
Chest wall recurrence after mastectomy does not always portend a dismal outcome.. 10. 2003
Results after rectal cancer resection with in-continuity partial vaginectomy and total mesorectal excision.. 10. 2003
Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity?. 10. 2003
Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma.. 10. 2003
A new agent, blue and radioactive, for sentinel node detection.. 10. 2003
Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.. 10. 2003
Resection of locally recurrent colorectal cancer in the presence of distant metastases: can it be justified?. 10. 2003
The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases.. 10. 2003
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy.. 10. 2003
Prediction of nonsentinel lymph node status in melanoma.. 10. 2003
Symptom control in patients with locally recurrent rectal cancer.. 10. 2003
Changes in breast cancer therapy because of pathology second opinions.. 9. 2002
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease.. 9. 2002
Breast-conservation therapy in early-stage breast cancer patients with a positive family history.. 9. 2002
The management of variant arterial anatomy during hepatic arterial infusion pump placement.. 9. 2002
Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence.. 9. 2002
Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status.. 9. 2002
Partial nephrectomy: the rationale for expanding the indications.. 9. 2002
Port site metastasis after diagnostic laparoscopy for upper gastrointestinal tract malignancies: an uncommon entity.. 9. 2002
Results after pancreatic resection for metastatic lesions.. 9. 2002
Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women.. 9. 2002
Long-term complications associated with breast-conservation surgery and radiotherapy.. 9. 2002
Prognoses of T4 breast cancer subsets.. 9. 2002
A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility.. 9. 2002
Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy.. 9. 2002
Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.. 9. 2002
Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved?. 9. 2002
Hürthle cell carcinoma: a 60-year experience.. 9. 2002
Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases.. 9. 2002
Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremity.. 9. 2002
Resection of the sciatic, peroneal, or tibial nerves: assessment of functional status.. 9. 2002
Solid-pseudopapillary tumor of the pancreas: a surgical enigma?. 9. 2002
A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels.. 8. 2001
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer.. 8. 2001
Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid.. 8. 2001
Patient reluctance toward tamoxifen use for breast cancer primary prevention.. 8. 2001
Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcome.. 8. 2001
Factors correlating with lymph node metastases in patients with T1 breast cancer.. 8. 2001
Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison.. 8. 2001
Laparoscopy predicts metastatic disease and spares laparotomy in selected patients with pancreatic nonfunctioning islet cell tumors.. 8. 2001
Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes.. 8. 2001
Role of fine-needle aspiration biopsy and frozen section analysis in the surgical management of thyroid tumors.. 8. 2001
VATS port site recurrence: a technique dependent problem.. 8. 2001
Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.. 8. 2001
Dendritic cells armed with anti-CD3 mAbs reduce pulmonary metastases, prolong survival, and engender antitumor effector cells demonstrable by adoptive transfer.. 7. 2000
Dermatofibrosarcoma protuberans of the head and neck.. 7. 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.. 7. 2000
Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?. 7. 2000
Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?. 7. 2000
Survival after resection of multiple hepatic colorectal metastases.. 7. 2000
Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer.. 7. 2000
Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.. 7. 2000
Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients.. 7. 2000
Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.. 7. 2000
Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma.. 7. 2000
Preoperative paclitaxel and radiotherapy for locally advanced breast cancer: surgical aspects.. 7. 2000
Women's regrets after bilateral prophylactic mastectomy.. 7. 2000
The type of urinary diversion after radical cystectomy significantly impacts on the patient's quality of life.. 7. 2000
Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma.. 6. 1999
Urinary diversion after total pelvic exenteration for rectal cancer.. 6. 1999
Issues of regret in women with contralateral prophylactic mastectomies.. 6. 1999
Pulmonary metastasectomy for head and neck cancers.. 6. 1999
Surgical oncology fellowship: viable pathway to academic surgery?. 6. 1999
Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience.. 6. 1999
Accurate prediction of the amount of in situ tumor in palpable breast cancers by core needle biopsy: implications for neoadjuvant therapy.. 6. 1999
Feasibility of immediate breast reconstruction for locally advanced breast cancer.. 6. 1999
Is lymphadenectomy necessary for early gastric cancer?. 6. 1999
Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies.. 6. 1999
Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy.. 6. 1999
Accuracy of AJCC staging for breast cancer patients undergoing re-excision for positive margins. American Joint Committee on Cancer.. 5. 1998
Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.. 5. 1998
Volume of resection in patients treated with breast conservation for ductal carcinoma in situ.. 5. 1998
Bilateral non-familial renal cell carcinoma.. 5. 1998
Comprehensive needs assessment of clinical breast evaluation skills of primary care residents.. 5. 1998
Detection of telomerase activity in breast masses by fine-needle aspiration.. 5. 1998
Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.. 5. 1998
Desmoplastic small round cell tumors: prognostic indicators and results of surgical management.. 5. 1998
Multifocal extremity sarcoma: an uncommon and controversial entity.. 5. 1998
Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas.. 5. 1998
Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome.. 5. 1998
Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction.. 5. 1998
Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases.. 5. 1998
Superficial extremity soft tissue sarcoma: an analysis of prognostic factors.. 5. 1998
Age-related differences in breast cancer stage at diagnosis between black and white patients in an urban community hospital.. 4. 1997
Retrospective review of 400 consecutive free flap reconstructions for oncologic surgical defects.. 4. 1997
Correlation of lipid content and composition with liposarcoma histology and grade.. 4. 1997
Pathologic findings at the time of nephrectomy for renal mass.. 4. 1997
Plantar flap reconstruction for acral lentiginous melanoma.. 4. 1997
Quality of life as defined by orthopedic oncology patients.. 4. 1997
Epithelioid sarcoma: clinical behavior and prognostic factors of survival.. 4. 1997
Long-term outcome of patients with perianal Paget's disease.. 4. 1997
Elevation of glutathione and related enzyme activities in high-grade and metastatic extremity soft tissue sarcoma.. 4. 1997
Low-risk differentiated thyroid cancer: the need for selective treatment.. 4. 1997
Microsatellite instability in breast cancer.. 4. 1997
Leiomyosarcoma in childhood and adolescence.. 4. 1997
Association between sucrase-isomaltase and p53 expression in colorectal cancer.. 4. 1997
Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens.. 4. 1997
Core needle biopsy for diagnosis of extremity soft tissue sarcoma.. 4. 1997
Nephrectomy during operative management of retroperitoneal sarcoma.. 4. 1997
Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery.. 3. 1996
Risk group stratification and prognostic factors in papillary carcinoma of thyroid.. 3. 1996
Follow-up in colorectal cancer patients: a cost-benefit analysis.. 3. 1996
Ureteral decompression in advanced nonurologic malignancies.. 3. 1996
The effect of blood transfusion on tumor growth in sarcoma-bearing rats.. 3. 1996
Improved survival in young women with breast cancer.. 2. 1995
Resection of brain metastases from sarcoma.. 2. 1995
Effect of reexcision on the success of breast-conserving surgery.. 2. 1995
Breast cancer after breast augmentation with silicone implants.. 2. 1995
Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience.. 2. 1995
Primary gastrointestinal sarcomas: analysis of prognostic variables.. 2. 1995
Use of laparoscopic techniques in oncologic right colectomy in a canine model.. 2. 1995
Ulcerative colitis and coexisting colorectal cancer: recurrence rate after restorative proctocolectomy.. 1. 1994
Acute metabolic effects of human recombinant tumor necrosis factor beta in the rat.. 1. 1994
Effect of growth hormone on tumor and host in an animal model.. 1. 1994
Effect of systemic insulin on protein kinetics in postoperative cancer patients.. 1. 1994
Effect of perioperative blood transfusion on recurrence and survival in 232 primary high-grade extremity sarcoma patients.. 1. 1994
Contribution of videothoracoscopy to the management of the cancer patient.. 1. 1994
Post-treatment sarcoma in breast cancer patients.. 1. 1994
Prognostic evaluation of intracranial metastasis in malignant melanoma.. 1. 1994
ASO Author Reflections: When to Operate Following Neoadjuvant Therapy for Locally Advanced Rectal Cancer?. 26. 2019
Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply.. 24. 2017
TNM: it is time to consider further expanding both the M stage as well as the R stage.. 18 Suppl 3. 2010
The importance of preoperative staging with chest CT scan in patients with colorectal cancer.. 18 Suppl 3. 2010
Author reply: Management of mild elevation of calcitonin after thyroidectomy.. 17. 2009
Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007.. 14. 2007
ASO Author Reflections: Disparities Among the Disaggregated Asian American Breast Cancer Population in New York City. 2023
ASO Author Reflections: Using the Cancer Genome Atlas to Investigate the Role of Genetics in Breast Cancer Disparities. 2023
ASO Author Reflections: Microsatellite Unstable Colon Cancer, Lymph Node Metastases, and Risk of Recurrence. 2023
ASO Author Reflections: Mediastinoscope-Assisted Esophagectomy: An Innovative Minimally Invasive Technique for Esophageal Resection. 2023
ASO Author Reflections: The Asian American Breast Cancer Population: Disaggregating the Monolith. 2023
ASO Author Reflections: Racial Disparities in Time to Breast Cancer Treatment-A Call to Action. 2022
ASO Author Reflections: Perioperative Genomic Profiles and Prognosis of Peripheral and Perihepatic Circulating Tumor DNA in Patients with Colorectal Liver Metastases. 2019
ASO Author Reflections: Predicting High-Risk Oncotype DX Recurrence Scores as a Strategy for Assessing Neoadjuvant Chemotherapy Eligibility. 2018
ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer. 2018
Nonsurgical evaluation of pathologic nipple discharge. 2003
An Observational Cohort Study Comparing Positive Margin Rates Using an Electromagnetic Navigational System Versus Wire Localization in Breast Conservation Surgery. 2024
Reply to "Multicentric Ipsilateral Invasive Breast Carcinomas Might Have Higher 21-Gene Recurrence Score Compared with Multifocal Ipsilateral Invasive Breast Carcinomas". 2018
In Reply: Alternative Ways to Study Global Variation in Cancer-Related Research Activity. 2018
Gastrectomy for patients with positive peritoneal cytology: comments on the article "Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients". 2011
Adequacy of distal resection margin following preoperative combined modality therapy for rectal cancer. 2003
2015 James Ewing Lecture: The 75-Year History of the Society of Surgical Oncology—Part II: The Transitional Years (1966–1990). 2016
2015 James Ewing Lecture: 75-Year History of the Society of Surgical Oncology-Part III: The Transformative Years (1991-2015). 2016
2015 James Ewing Lecture: The 75-Year History of the Society of Surgical Oncology-Part I: The Traditional Years (1940-1965). 2015
2010 SSO presidential address: subspecialty certificate in advanced surgical oncology. 2010
Lessons learned.. 2006
The enigma of local recurrence. The Society of Surgical Oncology. 1997
The Process that Defined the Discipline of Complex General Surgical Oncology and its Recognition by the American Board of Surgery. 2026
Invited Editorial About "Tumor Spread Through Air Spaces as a Predictor of Survival in Resected Pulmonary Lymphoepithelial Carcinoma" by Chen et al: Introducing the First Pathologic Grading System for PLEC.. 32. 2024
Even With the Best Surgical Technique; Biology will Always be King. 2024
Sowing the Seeds of Evasion: Lung Adenocarcinoma Plans Its Escape. 2023
Expanding Medicaid Improves Outcomes in Gynecologic Malignancies, But is it Enough?. 30. 2022
Disparities in Time to Treatment for Breast Cancer: Shifting Focus to the Root Cause.. 29. 2022
Disparities in Cancer Care: Educational Initiatives.. 29. 2022
Global Forum of Cancer Surgeons: Perspectives on Barriers to Surgical Care for Cancer Patients and Potential Solutions.. 26. 2019
Completion Node Dissection for Sentinel Node-Positive Melanoma: Can a Systematic Review Bring One Discussion to a Close While Leaving the Broader Conversation Still Open?. 26. 2019
The Age of Talking About Age Alone is Over.. 26. 2018
Global Forum of Cancer Surgeons: A Steady Voice for Cancer Surgeons to Improve Surgical Care for Cancer Patients Globally.. 25. 2018
AJCC 8th Edition: Colorectal Cancer.. 25. 2018
Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement.. 24. 2016
"Adjuvant" Hyperthermic Intraperitoneal Chemotherapy: A Call to Action.. 24. 2016
Margins in DCIS: Does Residual Disease Provide an Answer?. 23. 2016
Finish Line or Beginning? Welcome the New Board-certified Surgical Oncologists.. 23. 2016
Rectal Cancer: Time for Precision Medicine?. 23. 2015
Anaplastic Thyroid Cancer: Large Database, Cautious Interpretations.. 22. 2015
Attitudes and Perceptions of Surgical Oncology Fellows: The Right Voice at the Almost Right Time.. 22. 2015
Improving Sentinel Lymph Node Detection in Patients with Cervical Cancer.. 22. 2015
Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI.. 22. 2015
Metastatic Colorectal Cancer to the Liver: Involve the Surgeon Early and Often.. 22. 2015
Global surgical oncology: addressing the global surgical oncology disease burden.. 22. 2015
Extended surgical resection and histology in retroperitoneal sarcoma.. 22. 2014
Systemic therapy for patients with resectable hepatic colorectal metastases: improving patient selection.. 21. 2014
Multidisciplinary clinic in the management of hepatocellular carcinoma.. 21. 2013
Staging stage IV colorectal cancer.. 20. 2013
Update on the American Board of Surgery subspecialty certificate in Complex General Surgical Oncology.. 20. 2013
Low-risk thyroid cancer, surgical training, and radioactive iodine.. 20. 2012
Teach your children well: stage IV colorectal cancer and variability in practice patterns.. 19. 2012
The increasing credibility of sentinel lymph node mapping in endometrial cancer.. 20. 2012
Changing paradigms for liver resection of colorectal metastases.. 19. 2012
Lymph node yield and oncologic outcome after colorectal cancer resection.. 19. 2012
Circulating CD133: a promising biomarker, but what are we measuring?. 19. 2012
Clinical scoring systems for stratifying risk after resection of hepatic colorectal metastases: still relevant?. 18. 2011
Minimally invasive approach to breast cancer: is less better?. 18. 2011
American board of surgery certificate in complex general surgical oncology: a reality.. 18. 2011
To cut is to cure: can we really apply Z11 in practice?. 18. 2011
Are you too burnt out to read this? I expect not.. 18. 2010
7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.. 17. 2010
When is age more than just a number?. 17. 2010
Patterns of care with a positive sentinel node: echoes of an opportunity missed.. 16. 2009
The case for selective use of pre-operative chemotherapy for hepatic colorectal metastases: more is not always better.. 16. 2009
Staging of soft tissue sarcoma: what is new?. 15. 2008
Axillary surgery in DCIS: is less more?. 15. 2008
Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all.. 15. 2008
Knowledge helps, but alone it is not enough.. 15. 2008
Complications of neck dissection for thyroid cancer.. 15. 2007
Adjuvant therapy after resection of hepatic colorectal metastases.. 15. 2007
Editorial on "Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis".. 14. 2007
The management of asymptomatic skeletal breast cancer: a paradigm shift.. 14. 2007
Timing of the liver resection for patients with synchronous metastases: practical and outcome considerations.. 14. 2007
Lymphatic mapping and sentinel lymph node biopsy for locally recurrent breast cancer: new clues to understanding the biology of chest wall relapse.. 14. 2007
Local recurrence in soft tissue sarcoma: more about the tumor, less about the surgeon.. 14. 2007
The search for occult metastatic disease in breast cancer patients: how far should we go?. 13. 2006
Sentinel lymph node biopsy for breast cancer: will variations in technique influence long-term outcome?. 12. 2005
CD4 help and tumor immunity: beyond the activation of cytotoxic T lymphocytes.. 11. 2004
Combined modality therapy of esophageal cancer: changes in the standard of care?. 11. 2004
The prognostic importance of tumor mitotic rate for patients with primary cutaneous melanoma.. 11. 2004
Locoregional control of breast cancer: surgical technique does matter.. 11. 2004
Freezing breast cancers to enhance complete resection.. 10. 2003
Treatment of T2 gallbladder cancer.. 10. 2003
Risks of the uncontrolled retroperitoneum.. 10. 2003
Annals of surgical oncology impact factor/rating has dramatically increased.. 10. 2003
Retroperitoneal sarcoma: time for a national trial?. 9. 2002
More is less: systemic treatment for local control in soft tissue sarcoma.. 8. 2001
Insurance policies for prophylactic surgery: to cover or not to cover?. 7. 2000
Follow-up is valuable and effective: true, true and unrelated?. 7. 2000
A survival benefit from axillary dissection: was Halsted correct?. 6. 1999
Recurrent visceral sarcoma: new paradigm for an old problem?. 6. 1999
Staging of soft tissue sarcomas.. 6. 1999
Role of axillary dissection in breast cancer management.. 3. 1996
Head and neck surgery for the surgical oncologist.. 2. 1995
Benefit of aggressive multimodality treatment for gastric cancer.. 2. 1995
What is a surgical oncologist?. 1. 1994
Metastasis to the Thyroid Gland: A Critical Review. 2016
The GIST of targeted therapy for malignant melanoma. 2014
Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. 2010
Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. 2006
Tamoxifen for the prevention of breast cancer in the high-risk woman. 2000
Oncologic Anthropology and the African Diaspora: Twenty-Year Anniversary Report, International Center for the Study of Breast Cancer Subtypes (ICSBCS). 2025
The Landmark Series: Therapeutic Cancer Vaccine Strategies for Cold Tumors. 2025
Top Breast Oncology Articles from 2021 to Inform Your Cancer Practice. 2023
Social Determinants of Cancer Disparities. 2023
Landmark Series: The Cancer Genome Atlas and the Study of Breast Cancer Disparities. 2023
Novel Mediastinoscope-Assisted Minimally Invasive Esophagectomy for Esophageal Cancer: A Systematic Review and Meta-analysis. 2023
The Landmark Series: The Breast Cancer Burden of the Asian American Population and the Need for Disaggregated Data. 2023
The Landmark Series-Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women. 2022
Disparities in Surgical Oncology: Management of Advanced Cancer. 2021
Bias Issues in Colorectal Cancer Management: A Review. 2021
The Landmark Series: Hilar Cholangiocarcinoma. 2021
The Landmark Series: Non-melanoma Skin Cancers. 2019
The Androgen Receptor: Is It a Promising Target? 2017
Consensus Conference on North American Training in Hepatopancreaticobiliary Surgery: A Review of the Conference and Presentation of Consensus Statements. 2016
Is It Time to Centralize Ovarian Cancer Care in the United States? 2015
Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer. 2015
Global surgical oncology disease burden: addressing disparities via global surgery initiatives: the University of Michigan International Breast Cancer Registry. 2015
The role of U.S. cancer centers in global cancer care. 2015
Establishing translational and clinical cancer research collaborations between high- and low-income countries. 2015
Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature. 2015
The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer. 2014
Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. 2013
Prophylactic central neck dissection in differentiated thyroid cancer: an assessment of the evidence. 2013
Race and the molecular origins of breast cancer in Chinese women: breast cancer in Chinese women. 2012
Medullary thyroid carcinoma: ethical issues for the surgeon. 2012
Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition. 2011
Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. 2009
Germ cell tumors of the testis. 2005
Educational review: role of the surgeon in hereditary breast cancer. 2001
Gastric carcinoma. 1998
The impact of patterns of nodal metastasis on modifications of neck dissection. 1994

VIVO Weill Cornell Medical College

Annals of surgical oncology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)